Bansal, Meena
University Hospitals Birmingham NHS Foundation Trust · Inserm · Université Paris Cité · Sorbonne Université · University of Oxford · Centre de Recherche des Cordeliers · Centre de Recherche sur l'Inflammation · Physiopathologie et pharmacotoxicologie placentaire humaine : Microbiote pré & post natal · University of Birmingham · Newcastle University · Icahn School of Medicine at Mount Sinai
6 papers on CoChatORCID 0000-0002-7501-2191
Most cited papers
- Verified
A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis
Harrison, S. A., Bedossa, P., Guy, C. D., Schattenberg, J. M., Loomba, R., Taub, R., Labriola, D., Moussa, S. E., Neff, G. W., Rinella, M. E., et al. (2024) · New England Journal of Medicine
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 2,084
- Verified
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: Interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 1,277
- Verified
Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study
Chalasani, N., Bonkovsky, H. L., Fontana, R., Lee, W., Stolz, A., Talwalkar, J., Reddy, K. R., Watkins, P. B., Navarro, V., Barnhart, H., et al. (2015) · Gastroenterology
Drug-Induced Hepatotoxicity and ProtectionPharmacovigilance and Adverse Drug Reactions
Cited by 925
- Verified
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Harrison, S. A., Bashir, M. R., Guy, C. D., Zhou, R., Moylan, C. A., Frias, J. P., Alkhouri, N., Bansal, M. B., Baum, S., Neuschwander-Tetri, B. A., et al. (2019) · The Lancet
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 802
- Verified
Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes
Safadi, R., Ohta, M., Alvarez, C. E., Fiel, M. I., Bansal, M., Mehal, W. Z., & Friedman, S. L. (2004) · Gastroenterology
Liver physiology and pathologyDrug-Induced Hepatotoxicity and Protection
Cited by 239
- Verified
Opportunities and challenges following approval of resmetirom for MASH liver disease
Lazarus, J. V., Ivancovsky Wajcman, D., Mark, H. E., Younossi, Z. M., Kopka, C. J., Cohen, N., Bansal, M. B., Betel, M., & Brennan, P. N. (2024) · Nature Medicine
Liver Disease Diagnosis and TreatmentDrug-Induced Hepatotoxicity and Protection
Cited by 60
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free